Smartleaf Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Smartleaf Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.26K	Sell	102 -266	-72%	-$11.3K	﹤0.01%	2812
2025 Q4	$17.3K	Hold	368	–	–	﹤0.01%	2107
2025 Q3	$12.7K	Buy	368 +95	+35%	+$3.3K	﹤0.01%	2008
2025 Q2	$8.17K	Sell	273 -82	-23%	-$2.34K	﹤0.01%	1896
2025 Q1	$10.5K	Hold	355	–	–	﹤0.01%	1906
2024 Q4	$10.2K	Buy	355 +283	+393%	+$9.36K	﹤0.01%	1976
2024 Q3	$2.75K	Sell	72 -7	-9%	-$250	﹤0.01%	2371
2024 Q2	$2.56K	Buy	+79	New	+$2.74K	﹤0.01%	2126

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Smartleaf Asset Management's COLL Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 72% in Q1 2026, selling an estimated $11.3K and leaving 102 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #2812.

Smartleaf Asset Management first reported a position in COLL in Q2 2024 and has held it in 8 quarters since. The position peaked at $17.3K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Smartleaf Asset Management held 102 shares of Collegium Pharmaceutical worth $3.26K as of Q1 2026.
Smartleaf Asset Management sold 266 Collegium Pharmaceutical shares in Q1 2026, an estimated $11.3K.
Collegium Pharmaceutical made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2812 holding.
Smartleaf Asset Management first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
Smartleaf Asset Management's Collegium Pharmaceutical position peaked at $17.3K in Q4 2025.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.